Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Earli Inc.
Headquarters: South San Francisco, CA, United States of America
Website: https://www.earli.com/
Year Founded: 2018
Status: Private
BioCentury | Aug 22, 2024
Finance
Venture Report: Megarounds for BridgeBio newco, Pathalys and the latest from Versant
$300M raise for rare disease company GondolaBio headlines the week’s biggest venture rounds
BioCentury | Jul 11, 2023
Finance
Menlo Ventures continues scaling focus on tech-enabled bio
Menlo is looking to invest in generative AI for drug design and problem-solvers for gene editing — and to grow its healthcare team
BioCentury | Jan 20, 2021
Politics, Policy & Law
Biden’s science team & early cancer detection: a BioCentury podcast
As Joe Biden readies to become president, the shape of who will lead HHS, FDA, science policy and the new administration’s COVID-19 response is coming into focus. On the latest edition of the
BioCentury | Jan 15, 2021
Product Development
Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection
How two new early cancer detection companies aim to stand out from the pack
Items per page:
1 - 4 of 4